• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTIVION, INC. BIOGLUE SYRINGE 5-PACK, 5ML, G; GLUE, SURGICAL, ARTERIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTIVION, INC. BIOGLUE SYRINGE 5-PACK, 5ML, G; GLUE, SURGICAL, ARTERIES Back to Search Results
Model Number BG3515-5-G
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Anaphylactic Shock (1703)
Event Date 04/10/2023
Event Type  Injury  
Event Description
According to the manufacturer incident report (mir) received, "the device (bioglue surgical adhesive) was used as indicated, in this case to reinforce the suture line in the aorta following an aortic valve replacement.When the aortic cross clamp came off, the patient developed serious anaphylaxis which evolved gradually and required ongoing treatment with adrenalin, which went on for several hours post cardiopulmonary bypass.A tryptase rise confirmed the clinical impression of anaphylaxis.Allergy was confirmed on subsequent testing".
 
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to artivion is accurate or has been confirmed by artivion.
 
Manufacturer Narrative
A sample evaluation was not performed as no product was explanted or returned.The manufacturing records for were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.All lots passed functional testing and met release specifications.During the investigation no non-conformances or deviations were found to be related to the complaint.Based on the information provided, insufficient evidence is provided to definitively determine what caused the anaphylactic reaction.Additional information shows that the patient has pork-cat syndrome which results in a reaction to non-bovine albumin (cat with cross reactivity to pork).However, a potential cross reactivity reaction to bioglue cannot be excluded.The following is provided in the applicable bioglue instructions for use: ¿bioglue is not for patients with known sensitivity to materials of bovine origin." additionally, the following warning is provided within the ifu: "exercise caution with repeat exposure of bioglue in the same patient.Hypersensitivity reactions are possible upon exposure to bioglue.Sensitization has been observed in animals." the root cause of the observed event is unknown.However, a potential cross reactivity reaction to bioglue cannot be excluded.A review of ifu shows adequate precautions and warnings provided about the potential for allergic reaction.The bioglue surgical adhesive risk file was reviewed.The reported events are addressed in the a/dfmea.No samples were returned and a device history record (dhr) review was performed.No issues were found related to the reported lot number.The root cause of the observed event is unknown.However, a potential cross reactivity reaction to bioglue cannot be excluded.A review of ifu shows adequate precautions and warnings provided about the potential for allergic reaction.The reported events will continue to be monitored for trends.No updates to the rmf are needed in response to this complaint.Risk has been reduced as low as possible and overall residual risk is acceptable.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to artivion- formerly cryolife/jotec is accurate or has been confirmed by artivion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOGLUE SYRINGE 5-PACK, 5ML, G
Type of Device
GLUE, SURGICAL, ARTERIES
Manufacturer (Section D)
ARTIVION, INC.
1655 roberts blvd. nw
kennesaw GA 30144
Manufacturer (Section G)
ARTIVION, INC.
1655 roberts blvd. nw
kennesaw GA 30144
Manufacturer Contact
rochelle maney
1655 roberts blvd. nw
kennesaw, GA 30144
7704193355
MDR Report Key18893227
MDR Text Key337520626
Report Number1063481-2024-00004
Device Sequence Number1
Product Code MUQ
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
P010003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Model NumberBG3515-5-G
Device Lot NumberBG000908
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 02/21/2024
Initial Date FDA Received03/13/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/26/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured02/18/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age74 YR
Patient SexMale
-
-